Key stats
Market capitalization
12.645MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.6315USD
About Iterum Therapeutics plc
ISIN
IE000TTOOBX0
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
iterumtx.com
CEO
Corey N. Fishman
Headquarters
Dublin
Employees
14
Founded
2015
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
$ITRM idea **Not financial advice**
ITRM under $1 whilst being in NASDAQ, will need to reclaim the $1 before february. This will shoot up toward end of year whilst penny stocks are hot. looking to fill that $1.09 gap fill soon. Small amount of volume will send this. 15% risk at lows of 0.50 and potential profi
$ITRM can rise in the next daysContextual immersion trading strategy idea.
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States.
The demand for shares of the company looks higher than the supply.
This and othe
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0